Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy

The recommended control option against onchocerciasis is repeated ivermectin treatment, which will need to be implemented for decades, and it remains unknown how repeated ivermectin therapy might affect immunity against Onchocerca volvulus in the long term. O. volvulus-specific antibody reactivity a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mai, C S, Hamm, D M, Banla, M, Agossou, A, Schulz-Key, H, Heuschkel, C, Soboslay, P T
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2007
Assuntos:
Clinical Studies
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1810490/
https://ncbi.nlm.nih.gov/pubmed/17302900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2006.03312.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares